2020
Polypharmacy in HIV: recent insights and future directions.
Edelman EJ, Rentsch CT, Justice AC. Polypharmacy in HIV: recent insights and future directions. Current Opinion In HIV And AIDS 2020, 15: 126-133. PMID: 31833963, PMCID: PMC7543953, DOI: 10.1097/coh.0000000000000608.Commentaries, Editorials and LettersConceptsSeverity of illnessInappropriate medicationsDrug interactionsActual adverse eventsSubstance useTotal drug burdenMechanism of injuryElectronic health recordsNonantiretroviral medicationsUpdate findingsMore medicationsAdverse eventsDrug burdenClinical managementPolypharmacyDirect biomarkerMedicationsModifiable mechanismsPWHSicker individualsHealth recordsStrong associationHIVInjuryIllness
2018
Linkage to care and antiretroviral therapy initiation by testing modality among individuals newly diagnosed with HIV in Tanzania, 2014–2017
Rentsch CT, Wringe A, Machemba R, Michael D, Urassa M, Todd J, Reniers G, Zaba B. Linkage to care and antiretroviral therapy initiation by testing modality among individuals newly diagnosed with HIV in Tanzania, 2014–2017. Tropical Medicine And International Health 2018, 23: 1384-1393. PMID: 30282113, PMCID: PMC6334504, DOI: 10.1111/tmi.13153.Peer-Reviewed Original ResearchConceptsFacility-based VCTAntiretroviral therapy initiationTherapy initiationAntenatal clinicFacility-based HIV testingInitial CD4 cell countART initiation ratesCommunity-based HTCFacility-based HTCHIV serological testingCD4 cell countInitial CD4 countNew HIV diagnosesHIV-positive individualsRural Tanzanian communityCD4 countHIV diagnosisHIV testingSerological testingEarly diagnosisCell countLinkage rateRural wardsCells/HIV